<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin pubmed?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn></journal-meta><article-meta><article-id pub-id-type="pmid">15223613</article-id><article-id pub-id-type="doi">10.1080/09511920410001713484</article-id><article-id pub-id-type="pii">PXCKW20FHVVF8FYJ</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Merendino</surname><given-names>Rosaria Alba</given-names></name></contrib><contrib contrib-type="author"><name><surname>Di Pasquale</surname><given-names>Giuseppe</given-names></name></contrib><contrib contrib-type="author"><name><surname>De Luca</surname><given-names>Filippo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Di Pasquale</surname><given-names>Laura</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ferlazzo</surname><given-names>Edoardo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Martino</surname><given-names>Gabriella</given-names></name></contrib><contrib contrib-type="author"><name><surname>Palumbo</surname><given-names>Maura Carmela</given-names></name></contrib><contrib contrib-type="author"><name><surname>Morabito</surname><given-names>Fortunato</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gangemi</surname><given-names>Sebastiano</given-names></name></contrib></contrib-group><aff>Chair of Immunopathology, Department of Human Pathology, University of Messina, Italy.</aff><pub-date pub-type="ppub"><month>6</month><year>2004</year></pub-date><volume>13</volume><issue>3</issue><fpage>205</fpage><lpage>207</lpage><abstract><p>Moderate-severe depression (MSD) is linked to overexpression of proinflammatory cytokines and chemokines. Fractalkine (FKN) and macrophage inflammatory protein-1 alpha (MIP-1alpha) are, respectively, members of CX3C and C-C chemokines, and both are involved in recruiting and activating mononuclear phagocytes in the central nervous system. We analysed the presence of FKN and MIP-1alpha in sera of untreated MSD patients and healthy donors. High FKN levels were observed in all MSD patients as compared with values only detectable in 26% of healthy donors. MIP-1alpha was measurable in 20% of patients, while no healthy donors showed detectable chemokine levels. In conclusion, we describe a previously unknown involvement of FKN in the pathogenesis of MSD, suggesting that FKN may represent a target for a specific immune therapy of this disease.</p></abstract></article-meta></front></article> 